首页 | 本学科首页   官方微博 | 高级检索  
检索        

万拉法新与阿米替林治疗抑郁症对照观察
引用本文:高长青.万拉法新与阿米替林治疗抑郁症对照观察[J].中国医药导报,2010,7(11):60-61.
作者姓名:高长青
作者单位:云南省精神病医院,云南昆明,650224
摘    要:目的:探讨万拉法新治疗抑郁症的疗效与安全性。方法:将102例抑郁症患者随机分为两组,万拉法新组52例,阿米替林组50例,疗程8周,用汉密尔顿抑郁量表(HAMD)、副反应量表(TESS)评定疗效和不良反应。结果:万拉法新与阿米替林的总疗效比较,差异无统计学意义;万拉法新主要不良反应少于阿米替林。结论:万拉法新是一种安全、有效的抗抑郁药。

关 键 词:抑郁症  万拉法新  阿米替林  疗效  安全性

Effectiveness of Venlaflaxine and Amitriptyline in the treatment of depression
GAO Changqing.Effectiveness of Venlaflaxine and Amitriptyline in the treatment of depression[J].China Medical Herald,2010,7(11):60-61.
Authors:GAO Changqing
Institution:GAO Changqing (Yunnan Mental Hospital,Kunming 650224,China)
Abstract:Objective:To explore the efficacy and safety of Venlafaxine in the treatment of depression. Methods:102 cases of depression were randomly assigned into Venlafaxine group (n=52) and Amitriptyline group (n=50),the course of treatment was 8 weeks. The effects and side reactions were evaluated with Hamilton depression scale (HAMD) and treatment emergent symptom scale (TESS). Results:There was no significant difference in effectiveness between two groups. Venlafaxine had fewer side effects than Amitriptyline. Conclusion:Venlafaxine is a safe and effective antidepressant.
Keywords:Depression  Venlafaxine  Amitriptyline  Efficacy  Safety
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号